M.J.T.M. Mol

1.2k total citations
29 papers, 963 citations indexed

About

M.J.T.M. Mol is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, M.J.T.M. Mol has authored 29 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Cancer Research. Recurrent topics in M.J.T.M. Mol's work include Lipoproteins and Cardiovascular Health (13 papers), Cancer, Lipids, and Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). M.J.T.M. Mol is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Cancer, Lipids, and Metabolism (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). M.J.T.M. Mol collaborates with scholars based in Netherlands, Poland and United States. M.J.T.M. Mol's co-authors include Anton F. H. Stalenhoef, J.A. Gevers Leuven, Pierre N.M. Demacker, D.W. Erkelens, Yolanda B. de Rijke, Rune R. Frants, Louis M. Havekes, J. A. Schouten, Marten H. Hofker and Daniel Steinberg and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

M.J.T.M. Mol

29 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.J.T.M. Mol Netherlands 17 481 246 228 134 120 29 963
James M. Backes United States 17 482 1.0× 127 0.5× 227 1.0× 54 0.4× 88 0.7× 43 923
Hideaki Kurata Japan 16 215 0.4× 289 1.2× 198 0.9× 64 0.5× 84 0.7× 26 923
Oliver Weingärtner Germany 23 913 1.9× 368 1.5× 296 1.3× 161 1.2× 114 0.9× 65 1.5k
Bhalchandra J. Kudchodkar United States 23 571 1.2× 296 1.2× 321 1.4× 57 0.4× 174 1.4× 57 1.2k
Laurent Camont France 8 331 0.7× 233 0.9× 358 1.6× 67 0.5× 134 1.1× 12 896
Tu T. Nguyen United States 18 733 1.5× 207 0.8× 492 2.2× 69 0.5× 158 1.3× 30 1.3k
Bernhard Föger Austria 22 784 1.6× 377 1.5× 750 3.3× 49 0.4× 202 1.7× 52 1.6k
Hofit Cohen Israel 15 808 1.7× 505 2.1× 405 1.8× 43 0.3× 70 0.6× 47 1.4k
Sona Mitra United States 15 184 0.4× 337 1.4× 68 0.3× 472 3.5× 144 1.2× 27 1.1k
Timo P. Hiltunen Finland 19 276 0.6× 507 2.1× 338 1.5× 255 1.9× 110 0.9× 49 1.4k

Countries citing papers authored by M.J.T.M. Mol

Since Specialization
Citations

This map shows the geographic impact of M.J.T.M. Mol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.J.T.M. Mol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.J.T.M. Mol more than expected).

Fields of papers citing papers by M.J.T.M. Mol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.J.T.M. Mol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.J.T.M. Mol. The network helps show where M.J.T.M. Mol may publish in the future.

Co-authorship network of co-authors of M.J.T.M. Mol

This figure shows the co-authorship network connecting the top 25 collaborators of M.J.T.M. Mol. A scholar is included among the top collaborators of M.J.T.M. Mol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.J.T.M. Mol. M.J.T.M. Mol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menting, Juliane, Cees J. Tack, Arianne C. van Bon, et al.. (2017). Web-based cognitive behavioural therapy blended with face-to-face sessions for chronic fatigue in type 1 diabetes: a multicentre randomised controlled trial. The Lancet Diabetes & Endocrinology. 5(6). 448–456. 39 indexed citations
2.
Menting, Juliane, Stephanie Nikolaus, Ellen Bazelmans, et al.. (2015). A web-based cognitive behaviour therapy for chronic fatigue in type 1 diabetes (Dia-Fit): study protocol for a randomised controlled trial. Trials. 16(1). 262–262. 13 indexed citations
3.
Riksen, Niels P., M.J.T.M. Mol, Bert Bravenboer, et al.. (2012). Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study. Cardiovascular Diabetology. 11(1). 124–124. 26 indexed citations
4.
Boer, Mark de, M.J.T.M. Mol, M.J.J.T. Bogman, J M Galama, & Reinier Raymakers. (2003). Chronic active Epstein-Barr virus infection in an adult with no detectable immune deficiency.. PubMed. 61(11). 376–82. 4 indexed citations
5.
Mol, M.J.T.M., Yolanda B. de Rijke, Pierre N.M. Demacker, & Anton F. H. Stalenhoef. (1997). Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment. Atherosclerosis. 129(2). 169–176. 112 indexed citations
6.
Vlijmen, Bart J. van, M.J.T.M. Mol, Hans van der Boom, et al.. (1996). Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.. Journal of Clinical Investigation. 97(5). 1184–1192. 76 indexed citations
7.
Jong, Miek C., Vivian E.H. Dahlmans, Patrick J. van Gorp, et al.. (1996). Both Lipolysis and Hepatic Uptake of VLDL Are Impaired in Transgenic Mice Coexpressing Human Apolipoprotein E*3Leiden and Human Apolipoprotein C1. Arteriosclerosis Thrombosis and Vascular Biology. 16(8). 934–940. 52 indexed citations
8.
Benz, D., et al.. (1995). Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase. Journal of Biological Chemistry. 270(10). 5191–5197. 89 indexed citations
9.
Langner, Andrzej, et al.. (1993). Topical calcitriol in the treatment of chronic plaque psoriasis: a double-blind study. British Journal of Dermatology. 128(5). 566–571. 54 indexed citations
10.
Mol, M.J.T.M. & Anton F. H. Stalenhoef. (1993). HMG CoA reductase inhibitors. Current Opinion in Lipidology. 4(1). 41–48. 12 indexed citations
11.
Langner, Andrzej, et al.. (1992). 1α, 25-Dihydroxyvitamin D3 (calcitriol) ointment in psoriasis. Journal of Dermatological Treatment. 3(4). 177–180. 17 indexed citations
12.
Stuyt, P.M.J., M.J.T.M. Mol, & Anton F. H. Stalenhoef. (1991). Long‐term effects of simvastatin in familial dysbetalipoproteinaemia. Journal of Internal Medicine. 230(2). 151–155. 9 indexed citations
13.
Stuyt, P.M.J., M.J.T.M. Mol, A.F.H. Stalenhoef, Pierre N.M. Demacker, & A. van ‘t Laar. (1990). Simvastatin in the effective reduction of plasma lipoprotein levels in familial dysbetalipoproteinemia (type III hyperlipoproteinemia).. PubMed. 88(1N). 42N–45N. 11 indexed citations
14.
Mol, M.J.T.M., P.M.J. Stuyt, Pierre N.M. Demacker, & A.F.H. Stalenhoef. (1990). The effects of simvastatin on serum lipoproteins in severe hypercholesterolaemia.. PubMed. 36(3-4). 182–90. 7 indexed citations
15.
Mol, M.J.T.M., et al.. (1989). Low-density lipoprotein catabolism in WHHL rabbits after partial ileal bypass surgery. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1003(2). 167–174. 6 indexed citations
16.
Stalenhoef, Anton F. H., et al.. (1989). Efficacy and tolerability of simvastatin (MK-733). The American Journal of Medicine. 87(4A). S39–S43. 34 indexed citations
17.
Mol, M.J.T.M., et al.. (1989). EFFECTS OF INHIBITION OF CHOLESTEROL SYNTHESIS BY SIMVASTATIN ON THE PRODUCTION OF ADRENOCORTICAL STEROID HORMONES AND ACTH. Clinical Endocrinology. 31(6). 679–690. 20 indexed citations
18.
Mol, M.J.T.M., D. Willem Erkelens, J.A. Gevers Leuven, J. A. Schouten, & Anton F. H. Stalenhoef. (1988). Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia. Atherosclerosis. 69(2-3). 131–137. 68 indexed citations
19.
Swinkels, Dorine W., et al.. (1988). Some metabolic characteristics of low-density lipoprotein subfractions, LDL-1 and LDL-2: in vitro and in vivo studies. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 960(1). 1–9. 21 indexed citations
20.
Erkelens, D.W., et al.. (1988). Clinical Experience with Simvastatin Compared with Cholestyramine. Drugs. 36(Supplement 3). 87–92. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James M. Backes Breakdown of academic impact, for papers by Hideaki Kurata Breakdown of academic impact, for papers by Oliver Weingärtner Breakdown of academic impact, for papers by Bhalchandra J. Kudchodkar Breakdown of academic impact, for papers by Laurent Camont Breakdown of academic impact, for papers by Tu T. Nguyen Breakdown of academic impact, for papers by Bernhard Föger Breakdown of academic impact, for papers by Hofit Cohen Breakdown of academic impact, for papers by Sona Mitra Breakdown of academic impact, for papers by Timo P. Hiltunen
Rankless by CCL
2026